DC  Granules

Sr. No.

Product

Strength

Therapeutic Category

Status

1

Metformin HCl DC - IR

90%, 93.6%, 95%, 86.6% & 83.33% W/W

Anti-Diabetics

Commercially available with DMF

2

Metformin HCl DC - XR

69.44% W/W

Anti-Diabetics

Commercially available with DMF

3

Methocarbamol DC

90% W/W

Pain Medication

Commercially available with DMF

4

Guaifenesin DC

95% W/W

Expectorant

Commercially available with DMF

5

Fenofibrate DC

66% W/W

Lipid Modifying agent

R&D Developed

Pellets

Sr. No.

Product

Type and Strength

Status

1

Itraconazole - BP

22% / 44% w/w

R&D Developed

2

Esomeprazole Mg

Delayed Release 13.5% w/w

R&D Developed

3

Fenofibric Acid - BP

Delayed Release 29% w/w

R&D Developed

4

Omeprazole

Delayed Release 10.25% w/w

R&D Developed